Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) closed at $2.17 in the last session, up 2.84% from day before closing price of $2.11. In other words, the price has increased by $2.84 from its previous closing price. On the day, 1.02 million shares were traded. BDTX stock price reached its highest trading level at $2.21 during the session, while it also had its lowest trading level at $2.03.
Ratios:
We take a closer look at BDTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.24 and its Current Ratio is at 9.24. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $20.
Stifel Upgraded its Hold to Buy on June 30, 2023, whereas the target price for the stock was revised from $2 to $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Versant Venture Capital VI, L. sold 221,600 shares of BDTX for $1,400,556 on Aug 28 ’24. The 10% Owner now owns 3,726,341 shares after completing the transaction at $6.32 per share. On Jul 31 ’24, another insider, David Epstein, who serves as the Former Employer of the company, bought 50,000 shares for $6.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 123391848 and an Enterprise Value of -7421082. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 15.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.76 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at -0.106 whereas that against EBITDA is 10.365.
Stock Price History:
The Beta on a monthly basis for BDTX is 2.69, which has changed by -0.5694444 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $6.75, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is 32.70%, while the 200-Day Moving Average is calculated to be -25.94%.
Shares Statistics:
According to the various share statistics, BDTX traded on average about 3.37M shares per day over the past 3-months and 1542630 shares per day over the past 10 days. A total of 56.68M shares are outstanding, with a floating share count of 43.30M. Insiders hold about 23.86% of the company’s shares, while institutions hold 62.10% stake in the company. Shares short for BDTX as of 1745971200 were 9438498 with a Short Ratio of 2.80, compared to 1743379200 on 10174767. Therefore, it implies a Short% of Shares Outstanding of 9438498 and a Short% of Float of 23.959999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
